Assessing quality of life with SarQol is useful in screening for sarcopenia and sarcopenic obesity in older women

被引:5
|
作者
Fonfria-Vivas, Rosa [1 ,2 ]
Perez-Ros, Pilar [1 ,2 ]
Barrachina-Igual, Joaquin [3 ]
Pablos-Monzo, Ana [3 ]
Martinez-Arnau, Francisco M. M. [2 ,4 ]
机构
[1] Univ Valencia, Dept Nursing, Av Menendez Pelayo 19, Valencia 46010, Spain
[2] Univ Valencia, Frailty & Cognit Impairment Res Grp FROG, Menendez I Pelayo 19, Valencia 46010, Spain
[3] Univ Catolica Valencia San Vicente Martir, Fac Phys Act & Sport Sci, Ramiro de Maetzu 14, Valencia 46900, Spain
[4] Univ Valencia, Dept Physiotherapy, Gasco Oliag 5, Valencia 46010, Spain
关键词
Sarcopenia; Women; Sarcopenic obesity; Quality of life; Prevalence; SarQoL; MULTIPLE-SCLEROSIS; HEALTH; CONSENSUS; QUESTIONNAIRE; ASSOCIATION; DEFINITION; PREVALENCE; HISTORY; IMPACT; COSMIN;
D O I
10.1007/s40520-023-02488-7
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
BackgroundHealth-related quality of life (HRQoL) may be impaired in the presence of sarcopenia. Since a specific quality of life questionnaire became available for sarcopenia (SarQol), cutoffs to screen for this condition have been proposed, prompting the need to assess them in different populations. Due to the lack of consensus on diagnostic criteria, the tool has not yet been analyzed in screening for sarcopenic obesity.AimOur aim is to measure the SarQoL's metric properties and establish a cutoff in QoL assessments that could be used along the diagnostic pathway for sarcopenia and sarcopenic obesity in community-dwelling older women.MethodsThis cross-sectional study assessed women aged & GE; 70 years using the SarQol, sarcopenia criteria (EWGSOP2) and sarcopenic obesity criteria (ESPEN/EASO). Cutoffs for the SarQol were defined with a receiver-operating characteristics (ROC) curve, and sensitivity and specificity were analyzed.ResultsOf the 95 included women (mean age 76.0 years, standard deviation [SD] 5.7), 7.3% (n = 7) were classified as having sarcopenic obesity, 22.1% (n = 21) as having sarcopenia, and 70.5% (n = 67) as not having sarcopenia. The total SarQol score was higher in women without sarcopenia (66.5 SD 16.2) versus those with sarcopenia (56.6 SD 15.6) and sarcopenic obesity (45.1 SD 7.9). A cutoff of & LE; 60 points is proposed for sarcopenia screening (area under the ROC curve [AUC] 0.67; 95% confidence interval [CI] 0.53-0.80; sensitivity 61.9%; specificity 62%), and & LE; 50 points for sarcopenic obesity (AUC 0.85; 95% CI 0.74-0.95; sensitivity 71.4%; specificity 76.9%).ConclusionsQuality of life is compromised in women with sarcopenia and especially in those with sarcopenic obesity. The SarQol could be useful in screening for these conditions, providing insight into health-related quality of life in older people with sarcopenia.
引用
收藏
页码:2069 / 2079
页数:11
相关论文
共 50 条
  • [41] Cross-cultural adaptation and validation of Sarcopenia and Quality of Life (SarQoL) in Brazil
    Orlandi, Fabiana de Souza
    Nunes, Juliana Duarte
    dos Santos, Diana Gabriela Mendes
    Gratao, Aline Cristina Martins
    Zazzetta, Marisa Silvana
    SAO PAULO MEDICAL JOURNAL, 2023, 141 (01): : 30 - 35
  • [42] Sex Differences in Bone Health Among Indian Older Adults with Obesity, Sarcopenia, and Sarcopenic Obesity
    Anoohya Gandham
    David Scott
    Maxine P. Bonham
    Bharati Kulkarni
    Sanjay Kinra
    Peter R. Ebeling
    Ayse Zengin
    Calcified Tissue International, 2022, 111 : 152 - 161
  • [43] Sex Differences in Bone Health Among Indian Older Adults with Obesity, Sarcopenia, and Sarcopenic Obesity
    Gandham, Anoohya
    Scott, David
    Bonham, Maxine P.
    Kulkarni, Bharati
    Kinra, Sanjay
    Ebeling, Peter R.
    Zengin, Ayse
    CALCIFIED TISSUE INTERNATIONAL, 2022, 111 (02) : 152 - 161
  • [44] Prevalence of sarcopenia, sarcopenic obesity and their associations with metabolic syndrome in older people in Vietnam
    Nguyen, T.
    Nguyen, N-T
    Trung-Anh, N.
    Pham, T.
    Vu, H.
    AUSTRALASIAN JOURNAL ON AGEING, 2020, 39 : 34 - 34
  • [45] DEVELOPMENT OF A SELF-ADMINISTRATED QUALITY OF LIFE QUESTIONNAIRE SPECIFIC TO SARCOPENIA IN ELDERLY AGED 65 YEARS AND OLDER: THE SARQOL
    Beaudart, C.
    Biver, E.
    Reginster, J. -Y.
    Rizzoli, R.
    Rolland, Y.
    Bautmans, I.
    Petermans, J.
    Gillain, S.
    Buckinx, F.
    Van Beveren, J.
    Jacquemain, M.
    Italiano, P.
    Bruyere, O.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S145 - S145
  • [46] Translation and psychometric performance of the Serbian version of the Sarcopenia Quality of Life (SarQoL®) questionnaire
    Matijevic, Radmila
    Hrnjakovic, Olivera
    Durdevic, Aleksa
    Geerinck, Anton
    Beaudart, Charlotte
    Bruyere, Olivier
    Dulic, Oliver
    Harhaji, Vladimir
    Rasovic, Predrag
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2020, 148 (11-12) : 742 - 748
  • [47] Sarcopenia and sarcopenic obesity among older adults in the nordic countries: a scoping review
    Baygi, Fereshteh
    Buhl, Sussi Friis
    Thilsing, Trine
    Sondergaard, Jens
    Nielsen, Jesper Bo
    BMC GERIATRICS, 2024, 24 (01)
  • [48] Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia
    Beaudart, Charlotte
    Biver, Emmanuel
    Reginster, Jean-Yves
    Rizzoli, Rene
    Rolland, Yves
    Bautmans, Ivan
    Petermans, Jean
    Gillain, Sophie
    Buckinx, Fanny
    Dardenne, Nadia
    Bruyere, Olivier
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2017, 8 (02) : 238 - 244
  • [49] Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitions
    Charlotte Beaudart
    Médéa Locquet
    Jean-Yves Reginster
    Laura Delandsheere
    Jean Petermans
    Olivier Bruyère
    Aging Clinical and Experimental Research, 2018, 30 : 307 - 313
  • [50] Validation of the Lithuanian version of sarcopenia-specific quality of life questionnaire (SarQoL®)
    Vidmantas Alekna
    Justina Kilaite
    Marija Tamulaitiene
    Anton Geerinck
    Asta Mastaviciute
    Olivier Bruyère
    Jean-Yves Reginster
    Charlotte Beaudart
    European Geriatric Medicine, 2019, 10 : 761 - 767